2014 |
Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study. |
Roberta Diaz Brinton, Ph.D |
2014 |
External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1. |
Tally Largent-Milnes, PhD |
2014 |
Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. |
John M. Streicher, PhD |
2014 |
Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery. |
Patrick T Ronaldson, PhD |
2014 |
Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. |
Roberta Diaz Brinton, Ph.D |
2014 |
Drug delivery to the ischemic brain. |
Patrick T Ronaldson, PhD |
2014 |
Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury. |
Rajesh Khanna |
2014 |
Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. |
George Watts, Ph.D. |
2014 |
The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. |
Rajesh Khanna, May Khanna, PhD |
2014 |
Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. |
Rajesh Khanna, May Khanna, PhD |
2013 |
Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities. |
Victor Hruby, Ph.D., Josephine Lai , Ph.D., Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. |
Peg Davis, Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. |
Roberta Diaz Brinton, Ph.D |
2013 |
Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. |
Roberta Diaz Brinton, Ph.D |
2013 |
Effect of anchoring 4-anilidopiperidines to opioid peptides. |
Victor Hruby, Ph.D., Josephine Lai , Ph.D., Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. |
Patrick W Mantyh, Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD |
2013 |
Development of functionally selective, small molecule agonists at kappa opioid receptors. |
John M. Streicher, PhD |
2013 |
Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. |
Victor Hruby, Ph.D., Yeon Sun Lee, Todd Vanderah, PhD |
2013 |
Cancer-induced bone pain: Mechanisms and models. |
Todd Vanderah, PhD |
2013 |
Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1α transcriptional pathway. |
Roberta Diaz Brinton, Ph.D |
2013 |
Estrogen, astrocytes and the neuroendocrine control of metabolism. |
Roberta Diaz Brinton, Ph.D |
2013 |
Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons. |
John M. Streicher, PhD |
2013 |
Neurosteroids as regenerative agents in the brain: therapeutic implications. |
Roberta Diaz Brinton, Ph.D |
2013 |
Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes. |
George Watts, Ph.D. |
2013 |
Early decline in glucose transport and metabolism precedes shift to ketogenic system in female aging and Alzheimer's mouse brain: implication for bioenergetic intervention. |
Roberta Diaz Brinton, Ph.D |